Search

Displaying results 7801 - 7810 of 10000 in total
  1. Drug

    Aloe ferox leaf

    go.drugbank.com/drugs/DB14257
    Approved

    Aloe ferox leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Lu Hui (Aloe Ferox)
  2. Drug

    Nelumbo nucifera flower

    go.drugbank.com/drugs/DB14333
    Approved

    Nelumbo nucifera flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Bean of India Flower
  3. Drug

    Arnica montana flower

    go.drugbank.com/drugs/DB14343
    Approved

    Arnica montana flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Equisetum arvense top

    go.drugbank.com/drugs/DB14349
    ApprovedWithdrawn

    Equisetum arvense top is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Extract of the Sterile Caules of Equisetum Arvense
  5. Drug

    Salix alba bark

    go.drugbank.com/drugs/DB14274
    Approved

    Salix alba bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK. … Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C).

  7. Drug

    Ciluprevir

    go.drugbank.com/drugs/DB05868
    Investigational

    The compound, named BILN 2061, is an orally active inhibitor of the HCV NS3 protease and the first member of this new drug class to be tested in humans.

  8. Drug

    Cositecan

    go.drugbank.com/drugs/DB05806
    Investigational

    Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.

  9. Drug

    REN-850

    go.drugbank.com/drugs/DB05912
    Experimental

    REN-850 is an oral drug for multiple sclerosis which is in Phase I of clinical trials.

  10. Drug

    AdimrSC-2f

    go.drugbank.com/drugs/DB16436
    Investigational

    The AdimrSC-2f (SARS-CoV-2) vaccine is developed through Adimmune Corporation, the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia[L30553]. … A phase I study (NCT04522089) will investigate the safety and immunogenicity of the vaccine[L30553, L30548].